The peptide remains in Phase 3 clinical trials with Eli Lilly, with potential FDA approval expected sometime in late 2026 or early 2027
Never discontinue Ozempic without medical guidance, as abrupt cessation may lead to deterioration in glycaemic control
One boutique firm warned, Hims pivot to other meds wont offset the damageinvestors will stay wary. The mood swung from bullish to grim, with analysts questioning Hims ability to rebuild trust and navigate a tougher regulatory landscape
Is physician supervision important during medical weight loss treatment
In short, the ideal approach for most GLP-1 users emphasizes soluble fiber while including moderate amounts of insoluble fiber as tolerated
Australian Institute of Health and Welfare, Canberra de Vries EF, Los J, de Wit GA, Hakkaart-van Roijen L (2021) Patient, family and productivity costs of end-stage renal disease in the Netherlands